Inhibition of Fatty Acid Oxidation Promotes Macrophage Control of Mycobacterium tuberculosis

Author:

Chandra Pallavi12,He Li34,Zimmerman Matthew5,Yang Guozhe12,Köster Stefan6,Ouimet Mireille7,Wang Han5,Moore Kathyrn J.7,Dartois Véronique5ORCID,Schilling Joel D.34,Philips Jennifer A.12

Affiliation:

1. Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA

2. Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA

3. Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA

4. Cardiovascular Division, Department of Medicine; Washington University School of Medicine, St. Louis, Missouri, USA

5. Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA

6. Division of Infectious Diseases and Immunology, Department of Medicine, New York University Medical Center, New York, New York, USA

7. Marc and Ruti Bell Vascular Biology and Disease Program, Leon H. Charney Division of Cardiology, Department of Medicine, New York University Medical Center, New York, New York, USA

Abstract

Mycobacterium tuberculosis (Mtb) is the leading infectious disease killer worldwide. We discovered that intracellular Mtb fails to grow in macrophages in which fatty acid β-oxidation (FAO) is blocked. Macrophages treated with FAO inhibitors rapidly generate a burst of mitochondria-derived reactive oxygen species, which promotes NADPH oxidase recruitment and autophagy to limit the growth of Mtb. Furthermore, we demonstrate the ability of trimetazidine to reduce pathogen burden in mice infected with Mtb. These studies will add to the knowledge of how host metabolism modulates Mtb infection outcomes.

Funder

Center for Drug Discovery, Pfeiffer Foundation Drug Discovery Fund, Washington University

Potts Memorial Foundation

HHS | National Institutes of Health

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3